Vycor Medical Inc.'s Revolutionary ViewSite(TM) Neurosurgery Retraction Devices Adopted by the North Shore-LIJ Health System

BOHEMIA, NY--(Marketwire - April 14, 2010) - Vycor Medical, Inc. (OTCBB: VYCO) (www.vycormedical.com), a medical device company that designs, develops and markets next generation neurosurgery retraction devices, today announced it has signed a multi-year agreement with the North Shore-LIJ Health System (www.northshorelij.com) for the use of its ViewSite™ Brain Access System (VBAS) neurosurgery instruments. Vycor’s VBAS is already in use at two North Shore-LIJ hospitals, with others in their network -- and scores of other hospitals worldwide -- now considering the innovative neurosurgery retractors designed to be minimally invasive, produce less tissue trauma and maximize a surgeon’s field of vision -- all resulting in speedier, safer and more economical surgeries, a quicker patient discharge and accelerated recovery.

“We continually strive to keep our network of hospitals throughout Long Island, Queens and Staten Island at the forefront of patient care with state-of-the-art instrumentation and procedures,” said Raj Narayan, MD, chairman of neurosurgery at North Shore-LIJ. “Vycor’s ViewSite Brain Access System is not only highly cost effective, these progressive devices help us achieve our on-going goal of enhancing neurosurgical procedure performance, safety and results, thus adding value to our patients, staff and hospitals at large.”

“We are enthusiastic about the opportunity that this Agreement presents for our company and ViewSite Brain Access System product line,” said Heather N. Vinas, president of Vycor Medical, Inc. “We are a Long Island-based company and hold the entire North Shore-LIJ Health System in high reverence.”

“We’re focused on bringing effective products to market that allow the neurosurgical community to gain inroads,” continues Vinas. “We believe the ViewSite technology we have developed has the potential of simplifying complicated brain surgeries. These brain retractors allow neurosurgeons to have more precise access to the surgical field, as well as increased binocular vision of underlying tissue during brain surgery. Consequently, Vycor’s new surgical access system has the potential to reduce retraction injuries and other complications that can occur when surgeons are locating tumors.”

About Vycor Medical, Inc.
With corporate headquarters in Bohemia, NY, Vycor Medical, Inc. (OTCBB: VYCO) is a medical device company committed to making brain, spinal and other surgical procedures safer and more effective. The company’s flagship, Patent Pending ViewSite™ Surgical Access Systems represent an exciting new breed of retraction technology that holds the potential for speedier, safer and more economical brain, spinal and other surgeries and a quicker patient discharge. Vycor’s innovative medical instruments are designed to optimize neurosurgical site access, reduce patient risk, accelerate recovery, and add tangible value to the professional medical community. Vycor is ISO 13485:2003 compliant, has FDA 510(K) clearance for brain and spine surgeries, and CE marketing and HPB licensing in Canada. Learn more online at www.vycormedical.com.

About North Shore-LIJ Health System
As the largest healthcare provider in the region, North Shore-LIJ offers an unparalleled spectrum of high-quality services to meet all of its patients’ needs. The company’s vast resources are matched by a commitment to personalized health care -- whether treatment is provided at one of its 14 hospitals, centers of progressive care, long-term care facilities or through one of its home health agencies. With more than 7,500 world-class physicians, 9,500 nurses and other healthcare professionals, North Shore LIJ is dedicated to providing compassionate care in a safe, comfortable environment using the latest technology and treatment methods. Visit North Shore-LIJ online at www.northshorelij.com.

Safe Harbor Statement
Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “forecast”, “anticipate”, “estimate”, “project”, “intend”, “expect”, “should”, “believe”, and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Vycor Medical’s actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Vycor Medical’s filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Vycor Medical herein are expressly qualified in their entirety by the abovementioned cautionary statement. Vycor Medical disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.